India to United States: Gefitinib Export Trade Route
India has recorded 12 verified shipments of Gefitinib exported to United States, representing a combined trade value of $54.4K USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $4.5K USD. The leading Indian exporter is NATCO PHARMA LIMITED, which accounts for 86% of total export value with 1 shipments worth $47.0K USD. On the buying side, LIFE SCIENCE LOGISTICS is the largest importer in United States with $47.0K USD in purchases. The top 3 suppliers — NATCO PHARMA LIMITED, VINAYAK ASSOCIATES, MYGENIC HEALTHCARE PRIVATE LIMITED — together control 96% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Gefitinib corridor is one of India's established pharmaceutical export routes, with 12 shipments documented worth a combined $54.4K USD. The route is dominated by NATCO PHARMA LIMITED, which alone accounts for roughly 86% of all export value, reflecting the consolidated nature of India's gefitinib manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $4.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with gefitinib's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 30.0%, placing it at rank #11 among India's top gefitinib export destinations globally.
On the import side, key buyers of Indian gefitinib in United States include LIFE SCIENCE LOGISTICS, NA, COMERCIALIZADORA MEDENOR SA DE CV and 5 others. LIFE SCIENCE LOGISTICS is the single largest importer with 1 shipments valued at $47.0K USD.
Route Characteristics
- Average transit17 days
- Peak seasonQ4
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#11
- Annual growth+30.0%
- Demand growth+25.1%
- Regulatory ease83/100
Top 10 Indian Gefitinib Exporters to United States
Showing top 10 of 7 Indian suppliers exporting Gefitinib to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NATCO PHARMA LIMITED Avg $47.0K per shipment | 1 | $47.0K | 86.4% |
| 2 | VINAYAK ASSOCIATES Avg $1.6K per shipment | 2 | $3.1K | 5.7% |
| 3 | MYGENIC HEALTHCARE PRIVATE LIMITED Avg $997 per shipment | 2 | $2.0K | 3.7% |
| 4 | KOIT BIOPHARMA PRIVATE LIMITED Avg $1.7K per shipment | 1 | $1.7K | 3.2% |
| 5 | 3S CORPORATION Avg $432 per shipment | 1 | $432 | 0.8% |
| 6 | VEA IMPEX (I) PRIVATE LIMITED Avg $26 per shipment | 4 | $103 | 0.2% |
| 7 | VEA IMPEX I PRIVATE LIMITED Avg $12 per shipment | 1 | $12 | 0.0% |
This table shows the top 10 of 7 Indian companies exporting gefitinib to United States, ranked by total trade value. The listed exporters are: NATCO PHARMA LIMITED, VINAYAK ASSOCIATES, MYGENIC HEALTHCARE PRIVATE LIMITED, KOIT BIOPHARMA PRIVATE LIMITED, 3S CORPORATION, VEA IMPEX (I) PRIVATE LIMITED, VEA IMPEX I PRIVATE LIMITED. NATCO PHARMA LIMITED is the dominant supplier with 1 shipments worth $47.0K USD, giving it a 86% market share. The top 3 suppliers together account for 96% of the total trade value on this route.
Top 10 Gefitinib Importers in United States
Showing top 10 of 8 known buyers in United States receiving Gefitinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian gefitinib in United States include LIFE SCIENCE LOGISTICS, NA, COMERCIALIZADORA MEDENOR SA DE CV, SALVADOR DE LA TORRE, S LOG SA DE CV, among 8 total buyers. The largest importer is LIFE SCIENCE LOGISTICS, accounting for $47.0K USD across 1 shipments — representing 86% of all gefitinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LIFE SCIENCE LOGISTICS | 1 | $47.0K | 86.4% |
| 2 | NA | 2 | $3.1K | 5.7% |
| 3 | COMERCIALIZADORA MEDENOR SA DE CV | 1 | $1.7K | 3.2% |
| 4 | SALVADOR DE LA TORRE | 1 | $1.5K | 2.7% |
| 5 | S LOG SA DE CV | 1 | $500 | 0.9% |
| 6 | FOR THE ORDER OF | 1 | $432 | 0.8% |
| 7 | TO THE ORDER OF INVOICE RAISED TO | 4 | $103 | 0.2% |
| 8 | TO THE ORDER | 1 | $12 | 0.0% |
Top 10 Gefitinib Formulations Imported by United States
Showing top 10 of 11 product formulations shipped on the India to United States Gefitinib route, ranked by trade value
United States imports a wide range of gefitinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — GEFITINIB 250MG TABLETS 30'S (950 X30'S) — accounts for $47.0K USD across 1 shipments. There are 11 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GEFITINIB 250MG TABLETS 30'S (950 X30'S) | 1 | $47.0K | 86.4% |
| 2 | GEFITINIB 250MG TABLETS 1*10 STRIP (IR)BATCH: 60045144 60043484 / EXPIRY: 31-MAY-25 31-AUG-24PCS | 1 | $2.6K | 4.8% |
| 3 | IRESSA 250MG TAB / GEFITINIB | 1 | $1.7K | 3.2% |
| 4 | Iressa 250 mg Gefitinib Tab | 1 | $1.5K | 2.7% |
| 5 | GEFITINIB 250MG TABLETS 1*10 STRIP( GE)BATCH: AT2330A AT23642A / EXPIRY: 31-MAY-26 31-AUG-26PCS | 1 | $519 | 1.0% |
| 6 | IRESSA 250 MG TAB , GEFITINIB | 1 | $500 | 0.9% |
| 7 | GEFITINIB TABLETS IP 250 MG (TOTAL QTY 10 PACK) | 1 | $432 | 0.8% |
| 8 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS:GEFITAX 250 MG (30 Tab) (GEFITINIB) | 1 | $48 | 0.1% |
| 9 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS-GEFITAX 250 MG (30 TAB) GEFITINIB | 1 | $29 | 0.1% |
| 10 | GEFTISTED 250MG TAB (10 TABS) (GEFITINIB) | 2 | $27 | 0.0% |
Showing top 10 of 11 Gefitinib formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 80%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 6 shipments. Transit time averages 17 days by sea.
Market Dynamics
India's gefitinib exports to United States are driven primarily by a handful of large-scale manufacturers. NATCO PHARMA LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — NATCO PHARMA LIMITED, VINAYAK ASSOCIATES, MYGENIC HEALTHCARE PRIVATE LIMITED — together account for 96% of total trade value on this route. The average shipment value of $4.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as gefitinib 250mg tablets 1*10 strip (ir)batch: 60045144 60043484 / expiry: 31-may-25 31-aug-24pcs and iressa 250mg tab / gefitinib, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, LIFE SCIENCE LOGISTICS is the largest importer with 1 shipments worth $47.0K USD — representing 86% of all gefitinib imports from India on this route. A total of 8 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $54.4K
- Avg. Shipment
- $4.5K
- Suppliers
- 7
- Buyers
- 8
- Transit (Sea)
- ~17 days
- Annual Growth
- +30.0%
Reverse Direction
United States → India — Gefitinib (Import)Other Gefitinib Routes
Unlock the Full India to United States Gefitinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 12 shipments on this route.
Frequently Asked Questions — India to United States Gefitinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Gefitinib to United States?
The leading Indian exporters of Gefitinib to United States are NATCO PHARMA LIMITED, VINAYAK ASSOCIATES, MYGENIC HEALTHCARE PRIVATE LIMITED. NATCO PHARMA LIMITED holds the largest market share at approximately 86% of total trade value on this route.
Q What is the total value of Gefitinib exports from India to United States?
India exports Gefitinib to United States worth approximately $54.4K USD across 12 recorded shipments. The average value per shipment is $4.5K USD.
Q Which ports does India use to ship Gefitinib to United States?
The most active port of origin is SAHAR AIR with 6 shipments. Indian exporters primarily use sea freight for this route, with 80% of shipments going by sea and 26% by air.
Q How long does shipping take from India to United States for Gefitinib?
The average transit time for Gefitinib shipments from India to United States is approximately 17 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to United States Gefitinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 30.0% with demand growth tracking at 25.1%. The route is ranked #11 among India's top Gefitinib export destinations globally.
Q How many suppliers are active on the India to United States Gefitinib route?
There are currently 7 active Indian suppliers exporting Gefitinib to United States. The market is moderately concentrated with NATCO PHARMA LIMITED accounting for 86% of total shipment value.
Q Who are the main importers of Gefitinib from India in United States?
The leading importers of Indian Gefitinib in United States include LIFE SCIENCE LOGISTICS, NA, COMERCIALIZADORA MEDENOR SA DE CV, SALVADOR DE LA TORRE, S LOG SA DE CV. LIFE SCIENCE LOGISTICS is the largest buyer with 1 shipments worth $47.0K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Gefitinib.
- 2.Supplier/Buyer Matching: 7 Indian exporters and 8 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 12 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
12 Verified Shipments
7 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists